Your browser doesn't support javascript.
loading
Molecular testing for endometrial cancer: An SGO clinical practice statement.
Walsh, Christine S; Hacker, Kari E; Secord, Angeles Alvarez; DeLair, Deborah F; McCourt, Carolyn; Urban, Renata.
Affiliation
  • Walsh CS; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Colorado, Aurora, CO, United States of America. Electronic address: christine.2.walsh@cuanschutz.edu.
  • Hacker KE; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, New York University Langone Health, New York, NY, United States of America.
  • Secord AA; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Duke Cancer Institute, Durham, NC, United States of America.
  • DeLair DF; Department of Pathology, New York University Langone Health, New York, NY, United States of America.
  • McCourt C; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine, Saint Louis, MO, United States of America.
  • Urban R; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Washington, Seattle, WA, United States of America.
Gynecol Oncol ; 168: 48-55, 2023 01.
Article in En | MEDLINE | ID: mdl-36399812
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Endometrial Neoplasms Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Endometrial Neoplasms Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Document type: Article Country of publication: Estados Unidos